vs

Side-by-side financial comparison of CANTALOUPE, INC. (CTLP) and Fulgent Genetics, Inc. (FLGT). Click either name above to swap in a different company.

CANTALOUPE, INC. is the larger business by last-quarter revenue ($78.7M vs $71.1M, roughly 1.1× Fulgent Genetics, Inc.). On growth, CANTALOUPE, INC. posted the faster year-over-year revenue change (6.8% vs -3.2%). Over the past eight quarters, CANTALOUPE, INC.'s revenue compounded faster (7.7% CAGR vs 0.1%).

Cantaloupe, Inc., previously known as USA Technologies Inc., is an American company known for its work with ePort cashless acceptance technology running on its patented ePort Connect service, a PCI compliant services. ePort Connect wirelessly facilitates electronic payment options to consumers with credit, debit, or NFC enabled electronic wallets like Apple Pay and Google Pay while providing operators with both telemetry and machine-to-machine (M2M) services. ePort technology is primarily fou...

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

CTLP vs FLGT — Head-to-Head

Bigger by revenue
CTLP
CTLP
1.1× larger
CTLP
$78.7M
$71.1M
FLGT
Growing faster (revenue YoY)
CTLP
CTLP
+9.9% gap
CTLP
6.8%
-3.2%
FLGT
Faster 2-yr revenue CAGR
CTLP
CTLP
Annualised
CTLP
7.7%
0.1%
FLGT

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
CTLP
CTLP
FLGT
FLGT
Revenue
$78.7M
$71.1M
Net Profit
$-70.0K
Gross Margin
30.2%
Operating Margin
2.0%
21.1%
Net Margin
-0.1%
Revenue YoY
6.8%
-3.2%
Net Profit YoY
-101.4%
EPS (diluted)
$0.00
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTLP
CTLP
FLGT
FLGT
Q1 26
$71.1M
Q4 25
$78.7M
$83.3M
Q3 25
$80.9M
$84.1M
Q2 25
$82.6M
$81.8M
Q1 25
$75.4M
$73.5M
Q4 24
$73.7M
$76.2M
Q3 24
$70.8M
$71.7M
Q2 24
$72.7M
$71.0M
Net Profit
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
$-70.0K
$-23.4M
Q3 25
$-919.0K
$-6.6M
Q2 25
$6.8M
$-19.0M
Q1 25
$49.2M
$-11.5M
Q4 24
$5.0M
$-5.9M
Q3 24
$3.6M
$-14.6M
Q2 24
$2.2M
$-8.7M
Gross Margin
CTLP
CTLP
FLGT
FLGT
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
Q2 24
37.3%
Operating Margin
CTLP
CTLP
FLGT
FLGT
Q1 26
21.1%
Q4 25
2.0%
-43.5%
Q3 25
2.0%
-18.3%
Q2 25
6.3%
-24.1%
Q1 25
9.1%
-26.9%
Q4 24
8.4%
-21.2%
Q3 24
5.8%
-23.8%
Q2 24
4.9%
-26.6%
Net Margin
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
-0.1%
-28.1%
Q3 25
-1.1%
-7.9%
Q2 25
8.3%
-23.2%
Q1 25
65.2%
-15.7%
Q4 24
6.7%
-7.7%
Q3 24
5.0%
-20.4%
Q2 24
3.0%
-12.3%
EPS (diluted)
CTLP
CTLP
FLGT
FLGT
Q1 26
$0.04
Q4 25
$0.00
Q3 25
$-0.02
Q2 25
$0.10
Q1 25
$0.65
Q4 24
$0.07
Q3 24
$0.04
Q2 24
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTLP
CTLP
FLGT
FLGT
Cash + ST InvestmentsLiquidity on hand
$53.0M
$23.4M
Total DebtLower is stronger
$37.7M
Stockholders' EquityBook value
$252.5M
Total Assets
$381.9M
$1.2B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTLP
CTLP
FLGT
FLGT
Q1 26
$23.4M
Q4 25
$53.0M
$50.2M
Q3 25
$55.0M
$117.6M
Q2 25
$51.1M
$87.9M
Q1 25
$46.3M
$67.3M
Q4 24
$27.7M
$55.1M
Q3 24
$33.1M
$58.0M
Q2 24
$58.9M
$65.1M
Total Debt
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
$37.7M
Q3 25
$38.3M
Q2 25
$38.7M
Q1 25
$39.2M
Q4 24
$37.0M
Q3 24
$37.3M
Q2 24
$37.5M
Stockholders' Equity
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
$252.5M
$1.1B
Q3 25
$251.8M
$1.1B
Q2 25
$251.0M
$1.1B
Q1 25
$240.7M
$1.1B
Q4 24
$190.1M
$1.1B
Q3 24
$186.2M
$1.1B
Q2 24
$181.7M
$1.1B
Total Assets
CTLP
CTLP
FLGT
FLGT
Q1 26
$1.2B
Q4 25
$381.9M
$1.2B
Q3 25
$389.5M
$1.2B
Q2 25
$381.9M
$1.2B
Q1 25
$370.5M
$1.2B
Q4 24
$303.0M
$1.2B
Q3 24
$312.1M
$1.2B
Q2 24
$335.6M
$1.2B
Debt / Equity
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
0.15×
Q3 25
0.15×
Q2 25
0.15×
Q1 25
0.16×
Q4 24
0.19×
Q3 24
0.20×
Q2 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTLP
CTLP
FLGT
FLGT
Operating Cash FlowLast quarter
$3.1M
Free Cash FlowOCF − Capex
$-614.0K
FCF MarginFCF / Revenue
-0.8%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$25.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
$3.1M
$-78.1M
Q3 25
$7.0M
$11.1M
Q2 25
$9.4M
$-30.2M
Q1 25
$22.4M
$-4.4M
Q4 24
$522.0K
$25.0M
Q3 24
$-12.0M
$-15.5M
Q2 24
$14.3M
$4.3M
Free Cash Flow
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
$-614.0K
$-83.1M
Q3 25
$3.5M
$5.1M
Q2 25
$4.3M
$-37.0M
Q1 25
$18.6M
$-9.1M
Q4 24
$-3.8M
$21.2M
Q3 24
$-15.8M
$-35.0M
Q2 24
$8.5M
$-8.7M
FCF Margin
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
-0.8%
-99.7%
Q3 25
4.4%
6.0%
Q2 25
5.3%
-45.2%
Q1 25
24.6%
-12.5%
Q4 24
-5.1%
27.9%
Q3 24
-22.3%
-48.8%
Q2 24
11.7%
-12.2%
Capex Intensity
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
4.8%
6.0%
Q3 25
4.2%
7.2%
Q2 25
6.2%
8.3%
Q1 25
5.1%
6.4%
Q4 24
5.8%
5.0%
Q3 24
5.4%
27.2%
Q2 24
7.9%
18.2%
Cash Conversion
CTLP
CTLP
FLGT
FLGT
Q1 26
Q4 25
Q3 25
Q2 25
1.38×
Q1 25
0.46×
Q4 24
0.10×
Q3 24
-3.36×
Q2 24
6.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTLP
CTLP

Transaction Processing$47.9M61%
Subscription Revenue$21.8M28%
Products$9.0M11%

FLGT
FLGT

Segment breakdown not available.

Related Comparisons